A detailed history of Evergreen Capital Management LLC transactions in Argenx Se stock. As of the latest transaction made, Evergreen Capital Management LLC holds 452 shares of ARGX stock, worth $281,966. This represents 0.01% of its overall portfolio holdings.

Number of Shares
452
Holding current value
$281,966
% of portfolio
0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$434.22 - $551.9 $196,267 - $249,458
452 New
452 $245,000
Q1 2024

May 15, 2024

SELL
$356.95 - $413.29 $7,139 - $8,265
-20 Reduced 3.72%
518 $203,000
Q4 2023

Feb 14, 2024

SELL
$338.91 - $506.01 $16,945 - $25,300
-50 Reduced 8.5%
538 $204,000
Q3 2023

Nov 14, 2023

BUY
$369.35 - $548.43 $24,746 - $36,744
67 Added 12.86%
588 $289,000
Q2 2023

Aug 14, 2023

BUY
$360.14 - $422.58 $187,632 - $220,164
521 New
521 $203,000
Q4 2022

Feb 14, 2023

BUY
$342.17 - $402.31 $184,429 - $216,845
539 New
539 $204,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.5B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Evergreen Capital Management LLC Portfolio

Follow Evergreen Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evergreen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evergreen Capital Management LLC with notifications on news.